ArticleMolecular therapy. Oncology2025

Evaluation of dasatinib and ponatinib for the control of CD123 CAR-T cell functionalities.

Charles-Frédéric Mantion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.